| MA-60-79 | 24065 | VETERANS ADMINISTRATION SPECIFICATIONS PROMULGATED BY VETERANS ADMINISTRATION WASHINGTON DC |
| NAPROSYN 250 MG | 7A4E3 | GLENMARK PHARMACEUTICALS INC., USA |
| NAPROXYN | 26282 | SYNTEX LABORATORIES INC |
| NDC00093-0147-01 | 80608 | LEMMON CO |
| NDC00143-1346-01 | 32655 | HIKMA PHARMACEUTICALS USA INC. |
| NDC00364-2562-01 | 0PTT8 | SCHEIN PHARMACEUTICAL INC |
| NDC00378-0377-01 | 60895 | MYLAN PHARMACEUTICALS INC |
| NDC50228-0434-01 | 8NLP1 | SCIEGEN PHARMACEUTICALS INC |
| NDC55370-0139-07 | 1DZY7 | MOVA PHARMACEUTICAL CORP |
| NDC55953-0517-40 | 37360 | NOVOPHARM LTD |
| NDC65162-0188-10 | 00E55 | CARDINAL HEALTH, INC. |
| NDC65162-0188-10 | 557X3 | AMNEAL PHARMACEUTICALS OF NEW YORK, LLC |
| NDC68462-0188-01 | 7A4E3 | GLENMARK PHARMACEUTICALS INC., USA |